157 related articles for article (PubMed ID: 33147100)
1. Correcting Photo Reflection Method Output and Its Application in the Dynamic Analysis of Particle Release from Dry Powder Inhalers.
Kondo T; Hibino M; Tanigaki T; Tajiri S; Horiuchi S
J Aerosol Med Pulm Drug Deliv; 2021 Aug; 34(4):223-230. PubMed ID: 33147100
[No Abstract] [Full Text] [Related]
2. Optimal Inhalation Flow Pattern from Turbuhaler Predicted by Laser Photometry.
Kondo T; Hibino M; Tanigaki T; Tajiri S; Horiuchi S
J Aerosol Med Pulm Drug Deliv; 2022 Jun; 35(3):139-145. PubMed ID: 34637629
[No Abstract] [Full Text] [Related]
3. Impact of holding position during inhalation on drug release from a reservoir-, blister- and capsule-type dry powder inhaler.
Kondo T; Tanigaki T; Yokoyama H; Hibino M; Tajiri S; Akazawa K; Yamada Y; Cassan SM
J Asthma; 2017 Oct; 54(8):792-797. PubMed ID: 27929704
[TBL] [Abstract][Full Text] [Related]
4. Daily inhaled flow profiles and drug release from dry powder inhalers in patients with bronchial asthma.
Tajiri S; Kondo T; Tanigaki T; Hibino M; Asano K
Respir Med; 2022 Sep; 201():106950. PubMed ID: 35963030
[TBL] [Abstract][Full Text] [Related]
5. Numerical simulation of the effect of inhalation parameters, gender, age and disease severity on the lung deposition of dry powder aerosol drugs emitted by Turbuhaler®, Breezhaler® and Genuair® in COPD patients.
Horváth A; Farkas Á; Szipőcs A; Tomisa G; Szalai Z; Gálffy G
Eur J Pharm Sci; 2020 Nov; 154():105508. PubMed ID: 32836137
[TBL] [Abstract][Full Text] [Related]
6. Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease.
Bagherisadeghi G; Chrystyn H; Abadelah M; Larhrib EH
Eur J Pharm Sci; 2019 Nov; 139():105059. PubMed ID: 31472254
[TBL] [Abstract][Full Text] [Related]
7. Ventolin Diskus and Inspyril Turbuhaler: an in vitro comparison.
Broeders ME; Molema J; Burnell PK; Folgering HT
J Aerosol Med; 2005; 18(1):74-82. PubMed ID: 15741776
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Drug Release Dynamics of the Reservoir-type Dry Powder Inhalers.
Tajiri S; Kondo T; Tanigaki T; Asano K; Hibino M; Horiuchi S; Kobayashi I; Nishiya K
Tokai J Exp Clin Med; 2020 Sep; 45(3):102-107. PubMed ID: 32901895
[TBL] [Abstract][Full Text] [Related]
9. Use of inspiratory profiles from patients with chronic obstructive pulmonary disease (COPD) to investigate drug delivery uniformity and aerodynamic dose emission of indacaterol from a capsule based dry powder inhaler.
Abadelah M; Chrystyn H; Larhrib H
Eur J Pharm Sci; 2019 Jun; 134():138-144. PubMed ID: 31005623
[TBL] [Abstract][Full Text] [Related]
10. Total emitted dose of salbutamol sulphate at different inhalation flows and inhalation volumes through different types of dry powder inhalers.
Boshra MS; Almeldien AG; Salah Eldin R; Elberry AA; Abdelwahab NS; Nabil Salem M; Rabea H; Abdelrahim MEA
Exp Lung Res; 2018; 44(4-5):211-216. PubMed ID: 30346848
[TBL] [Abstract][Full Text] [Related]
11. The inhalation characteristics of patients when they use different dry powder inhalers.
Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
[TBL] [Abstract][Full Text] [Related]
12. [IS IT NECESSARY TO PROHIBIT SIDE-HOLE CLOSURE IN USE OF THE DRY POWDER INHALERS?].
Kondo T; Tanigaki T; Hibino M; Tajiri S; Horiuchi S; Fukuda M; Ohbayashi H
Arerugi; 2019; 68(2):96-100. PubMed ID: 30867367
[TBL] [Abstract][Full Text] [Related]
13. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction.
Broeders ME; Molema J; Hop WC; Folgering HT
J Aerosol Med; 2003; 16(2):131-41. PubMed ID: 12823907
[TBL] [Abstract][Full Text] [Related]
14. The effect of inspiratory parameters after two separate inhalations on the dose emission of theophylline from low and high resistance dry powder inhalers.
Abadelah M; Al-Assadi J; Rooney J; Larhrib H
Saudi Pharm J; 2020 Jan; 28(1):74-86. PubMed ID: 31920434
[TBL] [Abstract][Full Text] [Related]
15. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help?
Al-Showair RA; Tarsin WY; Assi KH; Pearson SB; Chrystyn H
Respir Med; 2007 Nov; 101(11):2395-401. PubMed ID: 17629471
[TBL] [Abstract][Full Text] [Related]
16. The clinical relevance of dry powder inhaler performance for drug delivery.
Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
[TBL] [Abstract][Full Text] [Related]
17. Real-Time Particle Emission Monitoring for the Non-Invasive Prediction of Lung Deposition via a Dry Powder Inhaler.
Hatazoe S; Hira D; Kondo T; Ueshima S; Okano T; Hamada S; Sato S; Terada T; Kakumoto M
AAPS PharmSciTech; 2024 May; 25(5):109. PubMed ID: 38730125
[TBL] [Abstract][Full Text] [Related]
18. Patient Inspiratory Maneuver Performance; Peak Lungpower, Acceleration and Volume.
Haikarainen J; Vahteristo M; Lähelmä S; Vartiainen V; Malmberg LP
J Aerosol Med Pulm Drug Deliv; 2020 Dec; 33(6):305-313. PubMed ID: 32423277
[No Abstract] [Full Text] [Related]
19. Practical problems with aerosol therapy in COPD.
Rau JL
Respir Care; 2006 Feb; 51(2):158-72. PubMed ID: 16441960
[TBL] [Abstract][Full Text] [Related]
20. Exhalation immediately before inhalation optimizes dry powder inhaler use.
Kondo T; Hibino M; Tanigaki T; Ohe M; Kato S
J Asthma; 2015; 52(9):935-9. PubMed ID: 26513654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
